spacer
home > pmps > Spring 2009
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Spring 2009
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. PMPS provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of PMPS.
   
Text
PDF
bullet
Manufacturing
Accenture's Global Pharma Industry Supply Chain & Tech Ops Study is investigating the latest macro trends across the pharmaceutical supply chain. Jay Welsh reports on the findings of the first wave of the study, concluding that there are a number of areas where processes can be streamlined.  
view
download pdf
Lyophilisation is often called for at a number of stages during the manufacturing process. Antonello A Barresi, Davide Fissore and Roberto Pisano at Politecnico di Torino present ways in which freeze-drying processes and recipes can be improved.  
view
download pdf
Aseptic processing is crucial for manufacturers wishing to guarantee product safety. Chuck Reed at Weiler Engineering, Inc introduces blow-fill-seal technology, and compares it to traditional methods of aseptic processing.  
view
download pdf
One of the roles of a manufacturer is to provide the first link in the crucial chain of product security. Diethard Schaefer at Schreiner Medipharm reveals how manufacturers ensure that they fulfil this role.  
view
download pdf
Continuing to look at the role of the manufacturer within the supply chain, Matthew Ottoway at Univar explores the options for distribution of pharmaceutical products.  
view
download pdf
bullet
Cool Chain, Cargo & Logistics
Passive cooling systems self-sufficiently maintain product temperature, without the need for electrical power. Developing such a system is a complex process and, argues Geraint Thomas at Laminar Medica, can be significantly aided by thorough preliminary research.  
view
download pdf
The journey by air can be particularly precarious for temperature-sensitive drugs, compared with road or sea logistics. Jonathan Neeld of CSafe updates us on the latest developments in air container technology, which can keep your products safe during flight.  
view
download pdf
Solid carbon dioxide - better known as dry ice - is commonly used in cold chain shipping, but is a potentially hazardous material. Karl Schlenker at Minnesota Thermal Science describes an incident which brought this safety concern into sharp relief, and outlines ways in which such accidents can be avoided.  
view
download pdf
The FDA's e-transformation initiative seeks to develop a system in which all regulated product information is stored electronically. Daniel R Matlis at Axendia explores the initiative, and outlines what it will mean for pharmaceutical companies.  
view
download pdf
bullet
Drug Delivery 
Michael N Eakins of Eakins & Associates discusses how manufacturers of glass products for parenteral delivery can maintain quality in their production line while building plants in a number of different countries.  
view
download pdf
The battle for patient compliance occurs at several points along the supply chain. Tassilo Korab at the HCPC Europe presents packaging strategies that can help win the fight.  
view
download pdf
bullet
Formulations, Ingredients and Excipients
Specially formulated excipients are often needed to hold together the active ingredients of a drug. Katleen Brys at Cargill Excipients discusses glucose monohydrate and its role as a binder in roller-compacted tablets.  
view
download pdf
bullet
PACKING, PACKAGING & ANTI-COUNTERFEITING
Bikash Chatterjee at Pharmatech Associates, Inc introduces e-pedigree: an integrated approach to track-and-trace, which seeks to promote security in the pharmaceutical supply chain.  
view
download pdf
Serial numbers have a crucial role to play in product security, uniquely identifying any given drug package. Joe Ringwood at Systech International analyses the benefits of a well-developed serialisation strategy.  
view
download pdf
bullet
CONTROLLED RELEASE
HIV/AIDS presents one of the most considerable challenges to scientists and pharmacists alike. Rhonda M Curran at Queen's University Belfast suggests that controlled release might hold the key for potentially revolutionary HIV-1 prevention drugs.  
view
download pdf

A significant number of oral controlled release solutions use degradable polymers; Aylvin A Dias and Marc Hendriks at DSM Biomedical look at the growing significance of this technology in the field.

 
view
download pdf
The formulation challenges facing manufacturers of adhesives for transdermal patches are considerable. John O'Mahony of Adhesives Research Ireland Ltd takes us through the factors that manufacturers need to consider in this market.  
view
download pdf
Mark Bünger at Lux Research offers a broader perspective on controlled release, examining the investments and partnerships that have been precipitated by the latest innovations in this sector of the industry.  
view
download pdf
   
spacer
Edited by
Randice Altschul
Chief Executive Officer at Pop Test and Palisades Therapeutics

Published quarterly in
February, May,
August and November

News and Press Releases

Prometic Bioseparations are very pleased to introduce their new purpose built ecommerce platform (Webshop)!

Their goal was to build a platform that is easy to navigate, informative and one that makes their products and services easily accessible to researchers and laboratories worldwide. They also wanted to make ordering as quick and easy as possible to meet the needs of the rapidly progressive industry. They have reflected these requirements with an ecommerce store in order to supply high quality products to customers from academia to big pharma.
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence and Post Translational Modifications of a Monoclonal Antibody

RSSL

Monoclonal antibodies are an important class of biopharmaceuticals. They are expressed from living cells and therefore, are subject to complex biochemical pathways. Not all of these pathways are fully understood and many are known to be sensitive to subtle environmental changes during production. These changes may affect the final biopharmaceutical sequence, structure and post-translational modifications. This is in addition to any changes that may occur during subsequent purification. This means that the final product from one batch may be subtly different from another batch. Furthermore, each batch is a heterogeneous mix of similar molecules. Analysis of the degree of batch-tobatch variation, and batch heterogeneity, is therefore, very important to establish in order to be confident that the drug is safe and effective for medicinal use.
More info >>

Industry Events

5th Annual Peptides Congress 2018

16-17 April 2018, Novotel London West Hotel, Hammersmith, London

Oxford Global Conferences are proud to present our highly anticipated 5th Annual Peptides Congress, 16th– 17th April 2018, London, UK. Over 450 peptides, proteins and antibodies attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement